These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16855833)

  • 1. Treating gliomas with glucocorticoids: from bedside to bench.
    Piette C; Munaut C; Foidart JM; Deprez M
    Acta Neuropathol; 2006 Dec; 112(6):651-64. PubMed ID: 16855833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: cannabinoid therapy for the treatment of gliomas?
    Velasco G; Galve-Roperh I; Sánchez C; Blázquez C; Guzmán M
    Neuropharmacology; 2004 Sep; 47(3):315-23. PubMed ID: 15275820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
    Kepes JJ
    Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenesis: biology and utility in the treatment of gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model.
    Wu ZP; Gao CW; Wu YG; Zhu QS; Yan Chen ; Xin Liu ; Chuen Liu
    Integr Cancer Ther; 2009 Mar; 8(1):88-92. PubMed ID: 19174507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial review: targets for glioma treatment: from bench to bedside.
    Sanson M
    Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting angiogenesis in malignant gliomas.
    Chi AS; Wen PY
    Handb Clin Neurol; 2012; 104():279-308. PubMed ID: 22230449
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antiglioma activity of radiotherapy and enzastaurin.
    Tabatabai G; Frank B; Wick A; Lemke D; von Kürthy G; Obermüller U; Heckl S; Christ G; Weller M; Wick W
    Ann Neurol; 2007 Feb; 61(2):153-61. PubMed ID: 17212356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumour stem cells in glioma--tomorrow's therapeutic target?].
    Christensen K; Schrøder HD; Kristensen BW
    Ugeskr Laeger; 2008 Sep; 170(38):2968-70. PubMed ID: 18808750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade gliomas: management issues.
    Duran I; Raizer JJ
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S15-21. PubMed ID: 18076313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids as potential new therapy for the treatment of gliomas.
    Parolaro D; Massi P
    Expert Rev Neurother; 2008 Jan; 8(1):37-49. PubMed ID: 18088200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.